TABLE 1.

MIC distribution for MAB (n = 27)^a,b

Antibiotics	Number of isolates with MIC (μg/mL) of:
	<0.06	0.06	0.12	0.2	0.5	1	2	4	8	16	32	64	>64	>152/8
CAM (3 days)	0	0	7	4	4	5	3	3	1	0	0	0	0
CAM (14 days)	0	0	0	6	4	0	0	0	0	1	0	0	16
AZM (3 days)	0	0	0	0	4	6	3	4	0	4	2	1	3
AZM (14 days)	0	0	0	0	0	2	5	3	0	0	0	0	17
AMK	0	0	0	0	0	0	0	3	18	4	2	0	0
TOB	0	0	0	0	0	0	1	6	12	7	1	0	0
IPM	0	0	0	0	0	0	0	0	16	9	2	0	0
MEPM	0	0	0	0	0	0	0	0	0	0	12	12	3
FRPM	0	0	0	0	0	0	0	0	0	0	0	0	27
LVFX	0	0	0	0	0	0	0	0	0	12	4	11	0
STFX	0	0	0	0	0	9	15	3	0	0	0	0	0
MFLX	0	0	0	0	0	0	0	4	4	19	0	0	0
DOXY	0	0	0	0	0	0	0	0	0	0	27	0	0
LZD	0	0	0	0	0	0	0	0	4	2	11	10	0
CLF	0	0	0	0	18	8	1	0	0	0	0	0	0
ST														27

^a Abbreviations: AMK, amikacin; AZM, azithromycin; CAM, clarithromycin; CLF, clofazimine; DOXY, doxycycline; FRPM, faropenem; IPM, imipenem; LVFX, levofloxacin; LZD, linezolid; MAB, Mycobacterium abscessus subsp. abscessus; MEPM, meropenem; MFLX, moxifloxacin; MIC, minimum inhibitory concentration; ST, sulfamethoxazole/trimethoprim; STFX, sitafloxacin; TOB, tobramycin.

^b Empty cells indicates that these MICs were not included as measurement items.